We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

72 hedge funds and large institutions have $206M invested in TriSalus Life Sciences in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

80% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 10

6% more funds holding

Funds holding: 68 → 72 (+4)

4.41% more ownership

Funds ownership: 89.24% → 93.66% (+4.4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less capital invested

Capital invested by funds: $219M → $206M (-$12.4M)

Holders
72
Holders Change
+4
Holders Change %
+5.88%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
18
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$7.64M
2
Bank of America
Bank of America
North Carolina
+$6.88M
3
UOC
UBS O'Connor
Illinois
+$5.96M
4
HSBC Holdings
HSBC Holdings
United Kingdom
+$4.23M
5
SCM
Shaolin Capital Management
Florida
+$2.03M

Top Sellers

Rank Fund Capital Flow
1
WAM
Weiss Asset Management
Massachusetts
-$11.1M
2
LA
Linden Advisors
New York
-$7.64M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$6.67M
4
Millennium Management
Millennium Management
New York
-$1.41M
5
KC
Kryger Capital
United Kingdom
-$551K
Name Holding Trade Value Shares
Change 		Change in
Stake
SV
26
Starboard Value
New York
$2.94M – – –
BCL
27
Bracebridge Capital LLC
Massachusetts
$2.92M – – –
Balyasny Asset Management
28
Balyasny Asset Management
Illinois
$2.82M – – –
DFCM
29
Dark Forest Capital Management
Puerto Rico
$2.81M +$267K +27,130 +11%
VI
30
Vestcor Inc
New Brunswick, Canada
$2.72M – – –
MA
31
MYDA Advisors
New York
$2.66M -$295K -30,000 -10%
BCM
32
Basso Capital Management
Connecticut
$2.46M – – –
SCM
33
Shaolin Capital Management
Florida
$2.04M +$2.03M +206,988 New
Barclays
34
Barclays
United Kingdom
$1.99M +$1.91M +194,264 +2,385%
Point72 Asset Management
35
Point72 Asset Management
Connecticut
$1.97M – – –
ZCA
36
Zeke Capital Advisors
Pennsylvania
$1.97M +$1.97M +200,000 New
GGHC
37
Gilder Gagnon Howe & Co
New York
$1.7M -$6.67M -679,216 -80%
SIA
38
SkyView Investment Advisors
New Jersey
$1.48M – – –
PC
39
Periscope Capital
Ontario, Canada
$1.38M +$389K +39,621 +40%
AA
40
AQR Arbitrage
Connecticut
$1.33M +$491K +50,000 +58%
KIM
41
Karpus Investment Management
New York
$1.29M – – –
FTCM
42
Fir Tree Capital Management
New York
$1.23M – – –
WRBC
43
W.R. Berkley Corp
Connecticut
$1.01M +$491K +49,999 +95%
CM
44
Cohanzick Management
New York
$984K +$491K +50,000 +100%
LCM
45
Landscape Capital Management
New Jersey
$977K – – –
Blackstone Inc
46
Blackstone Inc
New York
$758K – – –
SSA
47
Schonfeld Strategic Advisors
New York
$689K +$332K +33,806 +94%
FTCM
48
First Trust Capital Management
Illinois
$677K +$429K +43,693 +174%
CC
49
Centiva Capital
New York
$656K +$131K +13,347 +25%
CM
50
Crestline Management
Texas
$610K – – –
1
2
3 4

TLSI Hedge Fund Activity: Q2 2022 in Review

72 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q2 2022, worth a combined $206M — down 5.7% from $219M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new TLSI positions and 5 closed out — a net gain of 4 holders — while 18 added to existing stakes and 10 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $7.64M. The largest seller was Weiss Asset Management, cutting an estimated $11.1M.

  • 72 institutional investors held TriSalus Life Sciences (TLSI) as of Q2 2022, up from 68 in Q1 2022.
  • Funds reported $206M of TriSalus Life Sciences stock for Q2 2022, down 5.7% quarter-over-quarter.
  • 9 funds opened new TriSalus Life Sciences positions in Q2 2022 and 5 closed out, a net change of +4 holders.
  • The largest TriSalus Life Sciences buyer in Q2 2022 was Bank of Montreal, an estimated $7.64M added.
  • The largest TriSalus Life Sciences seller in Q2 2022 was Weiss Asset Management, an estimated $11.1M sold.

Based on aggregated 13F filings for Q2 2022.